Why the Earlypay (ASX:EPY) share price is going nuts

The share price of Earlypay Ltd (ASX:EPY) has flown higher, it's up more than 10% after releasing its FY21 half-year result to investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Earlypay Ltd (ASX: EPY) share price has gone nuts today, it's up more than 10% after announcing its FY21 half-year result.

Earlypay is a business that provides finance to small and medium businesses (SME) in the form of secured invoice financing and equipment financing. SMEs can receive an advance payment of up to 80% of a client's invoice to help cashflow pressures.

asx share price increase represented by golden dollar sign rocketing out from white domes of lithium

Image source: Getty Images

What was in the Earlypay result?

The company revealed that it generated $9.8 million of earnings before interest, tax, depreciation and amortisation (EBITDA), which was down 4% compared to the prior corresponding period.

Net profit after tax (NPAT), after adjusting for non-cash amortisation, was down 24% to $3.5 million.

Earlypay said that new business outcomes were accelerated by the acquisition of Skippr platform, with online applications representing 56% of new business in the second quarter after the launch in September 2020.

The company has been working on reducing its costs. It said it had achieved permanent cost savings of $1.5 million through the restructure of its funding lines during the second quarter of FY21.

Management were pleased with the company's performance in the first half considering the impacts on the SME market relating to COVID-19. Indicators point to a recovery across most metrics going into the second half.

Earlypay said that it showed resilience with no material defaults or losses through the peak of the COVID-19 downturn. It said that it's well provisioned against elevated SME insolvency risk as government support reduces in the coming months.

The company revealed that the second quarter group revenue was up 5% quarter on quarter to $11.1 million, the EBITDA grew 33% quarter on quarter to $5.6 million (with the EBITDA margin improving from 43% to 47% in the second quarter) and the NPATA increased 92% quarter on quarter to $2.3 million.

CEO commentary

Earlypay CEO Daniel Riley said:

Current volumes indicate that we are now back trading in excess of $2 billion total transaction value (TTV) on an annualised basis. This is due to an increase in funding requirements from existing clients, as well as new clients coming on board as our organic growth continues to build.

Restoring the Earlypay brand signified a return to our company's roots as a leader and innovator in the small business finance sector. The integration of the Skippr business, acquired in August 2020, is driving our digital transformation by improving client acquisition and client experience through new technology, while making our business more efficient. The firm-wide digital transformation is ongoing and we expect this investment in technology to drive organic revenue growth and operational efficiencies for years to come.

Earlypay dividend

The company's board decided to declare an interim dividend 1 cent per share. It didn't pay anything in the prior corresponding period.

Earlypay share price movements

Excluding today's gain, the Earlypay share price hadn't done much since the start of 2021. Over the last 12 months it's down 22%, though it has risen over 80% since the bottom of the share price at the end of FY20.

Outlook

It said that it's expecting to report record half-year earnings for the second half and has provided guidance of FY21 EBITDA to be more than $21 million, NPATA to be more than $8.5 million and a final dividend of 1.3 cents per share.

The company sees the second half of FY21 as a place from which it can start building growth again and capitalise on the digital changes it has made, as well as the improved client experience and bigger addressable market.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »